Quality in Details! New Packaging of Ranitidine-Darnitsa16 August 2021
The antiulcer drug Ranitidine-Darnitsa has changed its primary and secondary packaging.
In order to prevent the penetration of atmospheric moisture and oxygen inside the blister during storage, it was necessary to change the type of the primary packaging. From now on, the tablets are packed in an AluAlu blister. According to research data, AluAlu packaging provides the best barrier properties and protection of the product from atmospheric moisture, gases and light penetration. This allows the product to preserve its medicinal properties throughout the shelf life.
The design of the outer packaging has also changed. Now it is modern, convenient and informative for the patient. The package has a color coding in accordance with the symptoms addressed by the drug and icons to indicate the presentation form, while information on the dosage is additionally highlighted with color. An additional bonus is environmental friendliness - the amount of varnish used to cover the package was reduced during its production.